| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
| 11/14/2013 | US20130302339 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and or wnt |
| 11/13/2013 | EP2662089A2 Compstatin and analogs thereof for eye disorders |
| 11/13/2013 | EP2661433A1 Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd) |
| 11/13/2013 | EP2661279A2 Methods of treating age-related macular degeneration |
| 11/13/2013 | EP2661272A1 Artificial saliva comprising hyaluronic acid |
| 11/13/2013 | CN103391934A Dipyridylamine derivative |
| 11/13/2013 | CN103391782A Medicinal agent for prevention or treatment of diseases associated with intraocular neovascularization and/or intraocular vascular hyperpermeability |
| 11/13/2013 | CN103387580A Stemona root alkaloid monomer components and applications thereof |
| 11/13/2013 | CN103387259A Method of producing iodine seed used for treating eye disease or cancer, and iodine seed prepared by using the same |
| 11/13/2013 | CN103386057A Preparation method and application of stemona effective part extract |
| 11/13/2013 | CN103385994A Drug for treating otitis media |
| 11/13/2013 | CN103385979A Traditional Chinese medicine composite for treatment of hearing loss and tinnitus and preparation method thereof |
| 11/13/2013 | CN103385938A Medicament for eye care |
| 11/13/2013 | CN103385853A EGF liposome and preparation method thereof |
| 11/13/2013 | CN102370711B Meridian activating massage Chinese medicinal preparation and preparation method thereof |
| 11/13/2013 | CN102302481B Medicine composition for treating fungal keratitis |
| 11/13/2013 | CN101868455B Therapeutic substituted lactams |
| 11/12/2013 | US8580563 Placental stem cells |
| 11/12/2013 | CA2628508C Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy |
| 11/07/2013 | WO2013166041A1 Transthyretin ligands capable of inhibiting retinol-dependent rbp4-ttr interaction for treatment of age-related macular |
| 11/07/2013 | WO2013166030A2 Detecting complement activation |
| 11/07/2013 | WO2013164802A1 Complement pathway modulators and uses thereof |
| 11/07/2013 | WO2013164671A1 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension |
| 11/07/2013 | WO2013163758A1 Methods for treating and diagnosing blinding eye diseases |
| 11/07/2013 | US20130296442 Lutein/zeaxanthin for glare protection |
| 11/07/2013 | US20130295009 Method of treating inflammation |
| 11/06/2013 | EP2659911A1 Aqueous ophthalmic composition |
| 11/06/2013 | EP2659903A2 Nanoemulsion-type ophthalmic composition |
| 11/06/2013 | EP2659894A1 Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
| 11/06/2013 | EP2658529A2 Ocular drug delivery system |
| 11/06/2013 | CN103382216A Cyanoisoquinoline compounds and methods of use thereof |
| 11/06/2013 | CN103382201A Heteroaryl derivatives as cftr modulators |
| 11/06/2013 | CN103382176A Novel vanilloid receptor ligands and their use for producing medicaments |
| 11/06/2013 | CN103381217A Six-flavor hematinic capsule, its quality control method and application thereof |
| 11/06/2013 | CN103381150A Pharmaceutical composition and application thereof |
| 11/06/2013 | CN103381140A Inosine-common salt composition and preparation method thereof |
| 11/06/2013 | CN102743763B Drug for treating glaucoma |
| 11/06/2013 | CN102573813B 持续药物传递系统 Sustained drug delivery system |
| 11/06/2013 | CN102389411B Application of gallic acid in preparation of phosphodiesterase inhibitor anti inflammatory medicine |
| 11/06/2013 | CN102212093B Flavonoid glycoside compounds, method for preparing same and application |
| 11/06/2013 | CN102066402B Peptide derivative and composition for promoting tear secretion comprising the same |
| 11/06/2013 | CN101648004B Medicinal composition for treating eye diseases and application thereof |
| 11/06/2013 | CN101484391B Method for activating and stabilizing dissolved hydrogen in water |
| 11/06/2013 | CN101302515B Human antibodies that bind human TNF(alpha) |
| 11/05/2013 | US8575204 Nicotinamide derivates useful as P38 inhibitors |
| 11/05/2013 | US8574659 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 11/05/2013 | US8574613 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 11/05/2013 | US8574586 KDR peptides and vaccines comprising the same |
| 11/05/2013 | US8574585 KDR peptides and vaccines comprising the same |
| 11/05/2013 | CA2491994C Modulators of the glucocorticoid receptor |
| 10/31/2013 | WO2013163545A1 Use of n-acetylcysteine amide in the treatment of disease and injury |
| 10/31/2013 | WO2013163219A1 Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use |
| 10/31/2013 | WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same |
| 10/31/2013 | WO2013161871A1 Thiophene derivative having tlr-inhibiting activity |
| 10/31/2013 | WO2013161778A1 Method for producing an aqueous dispersion of drug nanoparticles and use thereof |
| 10/31/2013 | WO2013160879A1 Anti-robo4-antibody |
| 10/31/2013 | WO2013160359A1 Anti-pdgf-c antibodies |
| 10/31/2013 | WO2013090931A3 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases |
| 10/31/2013 | US20130287738 Disease-associated protein |
| 10/31/2013 | DE59209330C5 Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Benzimidazoles, pharmaceutical compositions containing them and methods for their preparation |
| 10/30/2013 | EP2657241A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 10/30/2013 | EP2657227A1 Novel substituted isoquinoline derivative |
| 10/30/2013 | EP2656839A1 Use of Cyclohexanehexol Derivatives in the Treatment of Ocular Diseases |
| 10/30/2013 | EP2656837A1 Lipid nanoparticles for treating ocular diseases |
| 10/30/2013 | EP2654771A1 Tear substitutes |
| 10/30/2013 | EP2654700A1 Otic composition for companion animals |
| 10/30/2013 | EP2654637A1 Kit-in-parts for cleaning and treating ears of companion animals |
| 10/30/2013 | CN203252935U Anti-senile and life-prolonging plaster |
| 10/30/2013 | CN103380112A Indole derivatives as modulators of S1P receptors |
| 10/30/2013 | CN103379906A Therapeutic agent for corneal sensory nerve damage containing semaphorin inhibitor as active ingredient |
| 10/30/2013 | CN103379904A Bromfenac aqueous liquid composition having preservative efficiency |
| 10/30/2013 | CN103373996A Bicyclic derivatives serving as CRTH2 receptor antagonist |
| 10/30/2013 | CN103372188A Preparation method of traditional Chinese medicine for treating pinkeye |
| 10/30/2013 | CN103372141A Medicine for traditional Chinese treatment of lacrimation induced by irritation of the wind |
| 10/30/2013 | CN103372117A Chinese medicinal composition for treating otitis and preparation method thereof |
| 10/30/2013 | CN103372111A Orally-taken medicament for Chinese medicine treatment of eye photophobia |
| 10/30/2013 | CN103372105A Eye care solution |
| 10/30/2013 | CN103372099A Eyesight improving eye drops |
| 10/30/2013 | CN103372092A Medicine for traditional Chinese treatment of swollen red eyes |
| 10/30/2013 | CN103372026A Empirical formula for eyes injured by electric arc |
| 10/30/2013 | CN103371971A Antiviral medicament for treating herpes simplex keratitis and method for preparing same |
| 10/30/2013 | CN103371923A Medical hydrogel eye mask and preparation method thereof |
| 10/30/2013 | CN102846942B Medicine for treating glaucoma and preparation method thereof |
| 10/30/2013 | CN102671061B Traditional Chinese medicine for treating chronic suppurative otitis media, as well as application and preparation method of same |
| 10/30/2013 | CN102648948B Fumigation Chinese medicinal composition for eye protection |
| 10/30/2013 | CN102526112B Sustained-release pearl clear-sighted eye drops and preparation method thereof |
| 10/30/2013 | CN102391095B Rheum emodin derivative and application thereof |
| 10/30/2013 | CN102036667B Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
| 10/29/2013 | US8569273 Ophthalmic formulations of cetirizine and methods of use |
| 10/29/2013 | US8568748 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 10/29/2013 | CA2469134C Novel peptide and pharmaceutical use of the same |
| 10/29/2013 | CA2434643C Peptides for activation and inhibition of.delta.pkc |
| 10/24/2013 | WO2013158739A1 Neuroprotective composition and method of use |
| 10/24/2013 | WO2013158661A1 Ocular drug delivery system |
| 10/24/2013 | WO2013157866A1 Composition for treating or preventing tinnitus |
| 10/24/2013 | WO2013157511A1 Arylaminopyrazole derivative |
| 10/24/2013 | WO2013155585A1 Sustained release device for thalidomide and use in eye diseases causing neovascularisation |
| 10/24/2013 | US20130281705 Compounds for the treatment of metabolic disorders |
| 10/24/2013 | US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |